Amgen USA INC
UEI XPGNQMXHP493 · CA · subsidiary of Amgen USA INC · SAM.gov record ↗
$149.9M
FY2025 obligations
7
Contract awards
Feb 25, 2020
First action
Jun 30, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$149.9M
- Department Of Veterans Affairs$-64K
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jul 26
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50122C00065 ↗ | EXERCISE OPTION PERIOD 3 CLINS 0010, 0011, AND 0012. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $150.0M | Sep 29, 2022 | Sep 28, 2032 |
| 36E79720D0006 ↗ | INCORPORATE 2025 FEDERAL CEILING PRICES INTO CONTRACT. NO CHANGES TO NATIONAL CONTRACT PRICES. | Department Of Veterans Affairs | 325412 | $0 | Feb 25, 2020 | — |
| 36E79725D0053 ↗ | NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS. | Department Of Veterans Affairs | 325412 | $0 | Nov 14, 2025 | — |
| 36F79721D0086 ↗ | FSS | Department Of Veterans Affairs | 325412 | $0 | Jan 31, 2021 | — |
| 36E79725D0009 ↗ | 2 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERIODS. | Department Of Veterans Affairs | 325412 | $0 | Feb 25, 2025 | — |
| 75A50124C00011 ↗ | DE-OBLIGATE FUNDING FOR CONTRACT CLOSEOUT. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $-42K | Mar 11, 2024 | Dec 15, 2024 |
| 36C26024F0036 ↗ | TAVNEOS (AVACOPAN) | Department Of Veterans Affairs | 325412 | $-64K | Sep 30, 2023 | Sep 29, 2024 |